Search research articles
Contact Us
Filters
Showing results (1-10 of 117) with videos related to
Page
of 12
Sort By:
British Journal of Pharmacology
|
March 5, 2011
Animal models in the drug discovery pipeline for Alzheimer's disease
Debby Van Dam, Peter Paul De Deyn
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 13, 2005
Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model
Debby Van Dam, Peter Paul De Deyn
Nature Reviews. Drug Discovery
|
November 3, 2006
Drug discovery in dementia: the role of rodent models
Debby Van Dam, Peter Paul De Deyn
Expert Opinion on Drug Discovery
|
December 15, 2016
Non human primate models for Alzheimer's disease-related research and drug discovery
Debby Van Dam, Peter Paul De Deyn
Neurobiology of Learning and Memory
|
November 18, 2005
Effect of Morris water maze diameter on visual-spatial learning in different mouse strains
Debby Van Dam, Guy Lenders, Peter Paul De Deyn
Medical Hypotheses
|
July 25, 2018
Intracranial pressure and glaucoma: Is there a new therapeutic perspective on the horizon?
Peter Wostyn, Debby Van Dam, Peter Paul De Deyn
Psychopharmacology
|
November 17, 2007
Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease
Debby Van Dam, Katrien Coen, Peter Paul De Deyn
Sleep Medicine Reviews
|
November 6, 2017
Sleep and Alzheimer's disease: A pivotal role for the suprachiasmatic nucleus
Jan Van Erum, Debby Van Dam, Peter Paul De Deyn
Epilepsy & Behavior : E&B
|
April 27, 2019
PTZ-induced seizures in mice require a revised Racine scale
Jan Van Erum, Debby Van Dam, Peter Paul De Deyn
Neuroscience and Biobehavioral Reviews
|
August 5, 2019
Alzheimer's disease: Neurotransmitters of the sleep-wake cycle
Jan Van Erum, Debby Van Dam, Peter Paul De Deyn
Page
of 12
Search research articles
Search
Showing results (1-10 of 117) with videos related to
Sort By:
Page
of 12
British Journal of Pharmacology
|
March 5, 2011
Animal models in the drug discovery pipeline for Alzheimer's disease
Debby Van Dam, Peter Paul De Deyn
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 13, 2005
Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model
Debby Van Dam, Peter Paul De Deyn
Nature Reviews. Drug Discovery
|
November 3, 2006
Drug discovery in dementia: the role of rodent models
Debby Van Dam, Peter Paul De Deyn
Expert Opinion on Drug Discovery
|
December 15, 2016
Non human primate models for Alzheimer's disease-related research and drug discovery
Debby Van Dam, Peter Paul De Deyn
Neurobiology of Learning and Memory
|
November 18, 2005
Effect of Morris water maze diameter on visual-spatial learning in different mouse strains
Debby Van Dam, Guy Lenders, Peter Paul De Deyn
Medical Hypotheses
|
July 25, 2018
Intracranial pressure and glaucoma: Is there a new therapeutic perspective on the horizon?
Peter Wostyn, Debby Van Dam, Peter Paul De Deyn
Psychopharmacology
|
November 17, 2007
Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease
Debby Van Dam, Katrien Coen, Peter Paul De Deyn
Sleep Medicine Reviews
|
November 6, 2017
Sleep and Alzheimer's disease: A pivotal role for the suprachiasmatic nucleus
Jan Van Erum, Debby Van Dam, Peter Paul De Deyn
Epilepsy & Behavior : E&B
|
April 27, 2019
PTZ-induced seizures in mice require a revised Racine scale
Jan Van Erum, Debby Van Dam, Peter Paul De Deyn
Neuroscience and Biobehavioral Reviews
|
August 5, 2019
Alzheimer's disease: Neurotransmitters of the sleep-wake cycle
Jan Van Erum, Debby Van Dam, Peter Paul De Deyn
Page
of 12